The recent FDA approval of Leqembi, the latest anti-amyloid drug, is undoubtedly a breakthrough for the field, providing a new way to slow the advancement of mild cognitive impairment or early-stage Alzheimer’s disease. As a practicing geriatrician who has treated Alzheimer’s patients for more than 40 years and the co-founder and chief science officer at the Alzheimer’s Drug […]

Retrospective cohort study presented at the American Diabetes Association 83rd Scientific Sessions analyzed real-world data of Dario users against matched controls to demonstrate a greater reduction when compared to non-users who achieve a 1.8 point reduction with the usual standard of care DarioHealth Corp. (“Dario” or the “Company”), a member in the global digital health […]

HDT Bio is developing messenger RNA vaccines addressing diverse indications in infectious diseases and oncology, and is utilizing regional partnerships for manufacturing, clinical development and commercialization. “Our model is designed to ensure that companies familiar with regional healthcare systems can maximize the probability of getting these vaccines to patients, saving lives and generating revenue,” Steven Reed, […]